Shoshana Shendelman, President and CEO at Applied Therapeutics Inc. (APLT), bought 125,000 shares at $10.00 ($1.3M) on 2019-05-16, disclosed to the SEC on 2019-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APLT | SELL | 2024-03-18 | $3.4M | — | Filing → |
| APLT | SELL | 2023-12-01 | $8K | — | Filing → |
| APLT | SELL | 2023-09-29 | $624K | — | Filing → |